Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Aurora Cannabis Inc (ACB) NPV

Sell:8.40 CAD Buy:8.46 CAD Change: 0.05 CAD (0.60%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Sell:8.40 CAD
Buy:8.46 CAD
Change: 0.05 CAD (0.60%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Sell:8.40 CAD
Buy:8.46 CAD
Change: 0.05 CAD (0.60%)
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Aurora Cannabis Inc is a Canada-based medical cannabis company. The Company’s principal strategic business lines are focused on the production, distribution and sale of cannabis in Canada and internationally. The Company is focused on offering its cannabis products to global medical cannabis market, consumer use cannabis market and global hemp-derived cannabidiol (CBD) markets. The Company offers varieties of cannabis infused products under various brands that includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and ROAR Sports. Its products portfolio includes dried cannabis, cannabis oil, soft-gels, oral dissolve strips, edibles, vaporizers and cannabis infused chocolates.

Contact details

Address:
4818 31 Street East
Edmonton International Airport
EDMONTON
T9E 0V6
Canada
Telephone:
+1 (604) 3625207
Website:
https://www.auroramj.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ACB
ISIN:
CA05156X8843
Market cap:
1.68 billion CAD
Shares in issue:
198.02 million
Sector:
Pharmaceuticals
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Ronald Funk
    Chairman of the Board
  • Miguel Martin
    Chief Executive Officer, Director
  • Glen Ibbott
    Chief Financial Officer
  • Allan Cleiren
    Chief Operational Officer
  • Jonathan Page
    Chief Scientific Officer
  • Jillian Swainson
    Chief Legal Officer, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.